BluePath Capital Management LLC increased its stake in The Cigna Group (NYSE:CI – Free Report) by 32.7% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 3,118 shares of the health services provider’s stock after purchasing an additional 768 shares during the period. BluePath Capital Management LLC’s holdings in The Cigna Group were worth $881,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other large investors have also recently added to or reduced their stakes in CI. AQR Capital Management LLC boosted its position in shares of The Cigna Group by 63.4% during the second quarter. AQR Capital Management LLC now owns 1,547,245 shares of the health services provider’s stock worth $510,467,000 after buying an additional 600,215 shares during the period. Ameriprise Financial Inc. lifted its stake in The Cigna Group by 23.4% in the 2nd quarter. Ameriprise Financial Inc. now owns 2,138,193 shares of the health services provider’s stock valued at $706,822,000 after acquiring an additional 405,694 shares in the last quarter. The Manufacturers Life Insurance Company boosted its position in The Cigna Group by 145.3% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 683,361 shares of the health services provider’s stock worth $225,899,000 after acquiring an additional 404,791 shares during the last quarter. International Assets Investment Management LLC raised its holdings in shares of The Cigna Group by 49,287.7% in the third quarter. International Assets Investment Management LLC now owns 400,040 shares of the health services provider’s stock valued at $138,590,000 after purchasing an additional 399,230 shares during the last quarter. Finally, Skandinaviska Enskilda Banken AB publ lifted its position in shares of The Cigna Group by 526.3% in the second quarter. Skandinaviska Enskilda Banken AB publ now owns 363,537 shares of the health services provider’s stock worth $120,174,000 after purchasing an additional 305,490 shares in the last quarter. Institutional investors own 86.99% of the company’s stock.
Analyst Upgrades and Downgrades
CI has been the subject of a number of analyst reports. Piper Sandler reaffirmed an “overweight” rating and issued a $394.00 target price (up previously from $392.00) on shares of The Cigna Group in a research report on Tuesday, November 5th. Truist Financial lowered their target price on The Cigna Group from $420.00 to $390.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Cantor Fitzgerald reissued an “overweight” rating and set a $400.00 price target on shares of The Cigna Group in a research report on Wednesday, October 23rd. Deutsche Bank Aktiengesellschaft decreased their price target on The Cigna Group from $398.00 to $394.00 and set a “buy” rating for the company in a research note on Monday, November 4th. Finally, Stephens reiterated an “overweight” rating and set a $410.00 price objective on shares of The Cigna Group in a research note on Friday, November 1st. One equities research analyst has rated the stock with a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus target price of $395.93.
The Cigna Group Trading Down 0.2 %
CI stock opened at $284.49 on Thursday. The Cigna Group has a one year low of $262.03 and a one year high of $370.83. The stock has a market cap of $79.13 billion, a price-to-earnings ratio of 26.84, a price-to-earnings-growth ratio of 0.88 and a beta of 0.54. The company has a fifty day moving average price of $303.49 and a two-hundred day moving average price of $327.70. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.72 and a quick ratio of 0.72.
The Cigna Group (NYSE:CI – Get Free Report) last announced its earnings results on Thursday, October 31st. The health services provider reported $7.51 EPS for the quarter, topping the consensus estimate of $7.22 by $0.29. The business had revenue of $63.70 billion during the quarter, compared to the consensus estimate of $59.58 billion. The Cigna Group had a net margin of 1.31% and a return on equity of 18.42%. The Cigna Group’s revenue was up 29.8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $6.77 EPS. Equities analysts anticipate that The Cigna Group will post 28.5 EPS for the current year.
The Cigna Group Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Thursday, December 19th. Stockholders of record on Wednesday, December 4th were paid a dividend of $1.40 per share. The ex-dividend date was Wednesday, December 4th. This represents a $5.60 dividend on an annualized basis and a dividend yield of 1.97%. The Cigna Group’s dividend payout ratio (DPR) is currently 52.83%.
About The Cigna Group
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
Read More
- Five stocks we like better than The Cigna Group
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Advance Auto Parts: Retail Trends Suggest Big Gains Ahead
- Options Trading – Understanding Strike Price
- 4 Social Media Stocks Set to Gain as TikTok Ban Looms
- 3 Warren Buffett Stocks to Buy Now
- How Do Stock Buybacks Affect Shareholders?
Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.